Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charalabos-Markos Dintsios

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Systematic Reviews|December 30, 2017
External validation of type 2 diabetes computer simulation models: definitions, approaches, implications and room for improvement-a protocol for a systematic reviewKatherine Ogurtsova, Thomas L Heise, Ute Linnenkamp, et al.
Pharmacoeconomics|July 27, 2025
Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology AssessmentsJörg Tomeczkowski, Tanja Heidbrede, Birte Eichinger, et al.
Health Policy (Amsterdam, Netherlands)|September 8, 2014
Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in GermanyJörg Ruof, Dietrich Knoerzer, Anja-Alexandra Dünne, et al.
International Journal of Methods in Psychiatric Research|February 16, 2018
Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims dataChristoph J Wagner, Charalabos Markos Dintsios, Florian G Metzger, et al.
European Journal of Gastroenterology & Hepatology|June 25, 2009
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in GermanyCharalabos-Markos Dintsios, Alexander Haverkamp, Johannes Wiegand, et al.
BMC Geriatrics|July 22, 2015
Implementation of a Multicomponent intervention to Prevent Physical Restraints In Nursing home residenTs (IMPRINT): study protocol for a cluster-randomised controlled trialJens Abraham, Ralph Möhler, Adrienne Henkel, et al.
The Patient|October 27, 2012
Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatmentMarjan J M Hummel, Fabian Volz, Jeannette G van Manen, et al.
Journal of the American Geriatrics Society|June 27, 2025
Cost-Effectiveness of Family Conferences to Reduce Polypharmacy in Frail Older AdultsJoseph Montalbo, Charalabos-Markos Dintsios, Jens Abraham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in GermanyGeorg Isbary, Thomas R Staab, Volker E Amelung, et al.
Health Economics Review|January 28, 2014
Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in GermanyInna Dabisch, Jürgen Dethling, Charalabos-Markos Dintsios, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Systematic Reviews|December 30, 2017
External validation of type 2 diabetes computer simulation models: definitions, approaches, implications and room for improvement-a protocol for a systematic reviewKatherine Ogurtsova, Thomas L Heise, Ute Linnenkamp, et al.
Pharmacoeconomics|July 27, 2025
Challenges and Criteria for Single-Arm Trials Leading to an Added Benefit in German Health Technology AssessmentsJörg Tomeczkowski, Tanja Heidbrede, Birte Eichinger, et al.
Health Policy (Amsterdam, Netherlands)|September 8, 2014
Analysis of endpoints used in marketing authorisations versus value assessments of oncology medicines in GermanyJörg Ruof, Dietrich Knoerzer, Anja-Alexandra Dünne, et al.
International Journal of Methods in Psychiatric Research|February 16, 2018
Longterm persistence and nonrecurrence of depression treatment in Germany: a four-year retrospective follow-up using linked claims dataChristoph J Wagner, Charalabos Markos Dintsios, Florian G Metzger, et al.
European Journal of Gastroenterology & Hepatology|June 25, 2009
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in GermanyCharalabos-Markos Dintsios, Alexander Haverkamp, Johannes Wiegand, et al.
BMC Geriatrics|July 22, 2015
Implementation of a Multicomponent intervention to Prevent Physical Restraints In Nursing home residenTs (IMPRINT): study protocol for a cluster-randomised controlled trialJens Abraham, Ralph Möhler, Adrienne Henkel, et al.
The Patient|October 27, 2012
Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatmentMarjan J M Hummel, Fabian Volz, Jeannette G van Manen, et al.
Journal of the American Geriatrics Society|June 27, 2025
Cost-Effectiveness of Family Conferences to Reduce Polypharmacy in Frail Older AdultsJoseph Montalbo, Charalabos-Markos Dintsios, Jens Abraham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in GermanyGeorg Isbary, Thomas R Staab, Volker E Amelung, et al.
Health Economics Review|January 28, 2014
Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in GermanyInna Dabisch, Jürgen Dethling, Charalabos-Markos Dintsios, et al.
Pageof 5